veriNOS pharmaceuticals GmbH services

Ronopterin – treatment to reduce retinal edema and improve patient outcomes. Adequate, pharmacologic control of retinal edema progression in diabetes is still insufficient. More than 50% of patients suffer from impairing side effects and require repetitive injections into the eye.

Ronopterin – treatment to reduce traumatic brain damage and improve patient outcomes. To date, we are still lacking a specific drug to treat the acute and long-term devastating consequences of traumatic brain injury.